Beckman Coulter, Inc. Medical Equipment Company Share Analysis

Publication Date	October 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	155
ISBN Number	not applicable
Product Code	GMD06022

Price

£685.00
approximately: $1,001 | €751

PDF

Order above formats by FAX

Summary

This report is an essential source for data, analysis and strategic insight into Beckman Coulter, Inc. The report provides key information relating to market share by sector and country, financial, SWOT and value chain analysis of the company. The report examines companys business structure and operations, history and products, and provides an analysis of its key revenue lines. It inspects the companys strategy, both in terms of its value chain positioning and strategic strengths and weaknesses.

Scope

Revenues for the markets and sub-sectors Beckman Coulter, Inc. operates in by country and region.
Detailed breakdowns of revenues and market share benchmarked against competitors.
Profiles of the pipeline of products that the company is developing.
Critical analysis of the companys strengths, weaknesses opportunities and threats and positioning on the value chain.
Provides summary analysis of key revenue lines and strategy.
Details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions.
Latest mergers and acquisitions, partnerships or financings of the company, including debt, equity or venture finance.

Reasons to buy

A single source to fulfill all of your business and competitor intelligence needs
Research your competitors business structure, strategy and prospects.
Counter your competitors strengths and target their weaknesses.
Identify your competitors key revenue streams by market and geography.
Identify and assess potential corporate and investment opportunities
Support sales activities by understanding your customers businesses better.
Identify potential competitor products before they reach market.
Qualify prospective partners and suppliers.

Content

1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 What Is This Report About?
3 Definitions of the Markets/Categories Covered
- 3.1 In Vitro Diagnostics
  - 3.1.1 Clinical Chemistry Test Reagents
  - 3.1.2 Immunochemistry Test Reagents
  - 3.1.3 Blood Test Reagents
  - 3.1.4 Self Testing
4 Company Snapshot
- 4.1 Key Information
- 4.2 Company Overview
- 4.3 Financial Performance
- 4.4 SWOT Snapshot
5 Business Description
- 5.1 Business Overview
- 5.2 Cellular Systems
  - 5.2.1 Overview
  - 5.2.2 Financials
  - 5.2.3 Market View
- 5.3 Chemistry Systems
  - 5.3.1 Overview
  - 5.3.2 Financials
  - 5.3.3 Market View
- 5.4 Discovery and Automation Systems
  - 5.4.1 Overview
  - 5.4.2 Financials
  - 5.4.3 Market View
- 5.5 Immunoassay Systems
  - 5.5.1 Overview
  - 5.5.2 Financials
  - 5.5.3 Market View
  - 5.5.4 Key Strategies
- 5.6 Major Products and Services
  - 5.6.1 Overview
6 History
7 Business Strategy
- 7.1 Mission Statement
- 7.2 Strategy
- 7.3 Corporate Social Responsibility
  - 7.3.1 Overview
  - 7.3.2 Specific CSR Initiatives
8 Value Chain Analysis
- 8.1 Manufacturing
  - 8.1.1 In House Manufacturing
- 8.2 Product Development
  - 8.2.1 Regulatory Approvals
  - 8.2.2 Research and Development
- 8.3 Sales and Marketing
  - 8.3.1 Partnerships and Alliances
  - 8.3.2 Licensing Agreements
9 SWOT Analysis
- 9.1 Overview
- 9.2 Beckman Coulter, Inc. Strengths
  - 9.2.1 Consistent Financial Growth
  - 9.2.2 Broad Product Portfolio
  - 9.2.3 Focused Research and Development Activities
- 9.3 Beckman Coulter, Inc. Weaknesses
  - 9.3.1 Dependence on the U.S. Region
  - 9.3.2 Lawsuits
- 9.4 Beckman Coulter, Inc. Opportunities
  - 9.4.1 New Product Launches
  - 9.4.2 Licensing Agreements
  - 9.4.3 Increasing Clinical Diagnostic Market
- 9.5 Beckman Coulter, Inc. Threats
  - 9.5.1 Competition
  - 9.5.2 Formation of Group Purchasing Organizations
  - 9.5.3 Reductions in Government Funding
10 Competitors
11 Beckman Coulter, Inc. Medical Equipment Market Share Analysis
- 11.1 Beckman Coulter, Inc., In Vitro Diagnostics, Global, Market Share (2007)
- 11.2 Beckman Coulter, Inc., In Vitro Diagnostics, APAC, Market Share (2007)
- 11.3 Beckman Coulter, Inc., In Vitro Diagnostics, Europe, Market Share (2007)
- 11.4 Beckman Coulter, Inc., In Vitro Diagnostics, MEA, Market Share (2007)
- 11.5 Beckman Coulter, Inc., In Vitro Diagnostics, North America, Market Share (2007)
- 11.6 Beckman Coulter, Inc., In Vitro Diagnostics, SCA, Market Share (2007)
12 Beckman Coulter, Inc. Medical Equipment Market Share Analysis by Category
- 12.1 Beckman Coulter, Inc., Global, Market Share (2007)
- 12.2 Beckman Coulter, Inc., APAC, Market Share (2007)
- 12.3 Beckman Coulter, Inc., Europe, Market Share (2007)
- 12.4 Beckman Coulter, Inc., MEA, Market Share (2007)
- 12.5 Beckman Coulter, Inc., North America, Market Share (2007)
- 12.6 Beckman Coulter, Inc., SCA, Market Share (2007)
13 Revenue Analysis
- 13.1 Revenue by Segment
- 13.2 Revenue by Geography
14 Financial and Operational Review
- 14.1 Financial Statements
- 14.2 Financial Ratios
15 Share Holding Structure
16 Key Employees
17 Key Employee Biographies
18 Company Statement
19 Locations And Subsidiaries
- 19.1 Head Office
- 19.2 Other Locations & Subsidiaries
20 Financial Deals Landscape
- 20.1 Acquisition
  - 20.1.1 Beckman Coulter Acquires Dako Colorado from Dako Denmark
  - 20.1.2 Beckman Coulter Acquires NexGen Diagnostics
  - 20.1.3 Beckman Coulter Acquires Lumigen
  - 20.1.4 Beckman Coulter Acquires Agencourt Bioscience
- 20.2 Debt Offerings
  - 20.2.1 Beckman Coulter Completes Private Placement of $600 Million
  - 20.2.2 AcroMetrix Enters Into a Partnership Agreement with Beckman Coulter
  - 20.2.3 Beckman Coulter Enters Into Licensing Agreements for Molecular Tests with National University of Ireland
  - 20.2.4 Beckman Coulter Signs an Agreement with Johns Hopkins University
  - 20.2.5 Beckman Coulter Enters Into A Licensing Agreement with Dade Behring
  - 20.2.6 Beckman Coulter Signs Licensing Agreement with Roche
21 Recent Developments
- 21.1 Product Announcements
  - 21.1.1 Aug 18, 2008 Beckman Coulter Initiates Clinical Trials Phase of Test Development Program
  - 21.1.2 Aug 18, 2008 Beckman Coulter Initiates Test Development Program Clinical Trials
  - 21.1.3 Mar 07, 2008 Beckman Coulter, Inc. Releases the High-Volume UniCel DxC 880i Integrated Work Cell
  - 21.1.4 Jan 21, 2008 Minister Martin Announces Significant R&D Collaboration for Beckman Coulter and NUI Galway
  - 21.1.5 Jan 31, 2007 Beckman Coulter Integrates New BioRAPTR Workstation for High-Throughput Assay Miniaturization
  - 21.1.6 Nov 20, 2006 Beckman Coulter's EPO Assay Approved By FDA
  - 21.1.7 Jan 01, 2005 Beckman Coulter Offers Cyanide-Free Reagents for COULTER LH 500 Hematology Analyzer
  - 21.1.8 Jan 01, 2005 Beckman Coulters New Version of DL2000 Data Manager Boasts Enhanced Features for Improved Laboratory Workflow
  - 21.1.9 Oct 01, 2004 21 CFR Part 11 Software for Automated Benchtop Flow Cytometry System
  - 21.1.10 May 04, 2004 Beckman Coulter Launches High-Volume ACL TOP Coagulation Analyzer With Extensive Test Menu
  - 21.1.11 Aug 08, 2003 Beckman Coulter Announces New GenomeLab Initiative
  - 21.1.12 Aug 01, 1999 Newest COULTER HmX Hematology Flow Cytometer
  - 21.1.13 Nov 07, 2007: Beckman Signs Agreements with MedAssets
  - 21.1.14 Apr 02, 2007: Beckman Signs Pact with Premier to Provide Core Laboratory Systems
- 21.2 Financial Announcements
  - 21.2.1 Jul 25, 2008: Beckman Reports 2Q 2008 Results
  - 21.2.2 Jul 21, 2008: Beckman Declares Quarterly Dividend
  - 21.2.3 Apr 30, 2008: Beckman Declares Q1 2008 Results
  - 21.2.4 Apr 25, 2008: Beckman Declares Quarterly Dividend
  - 21.2.5 Apr 11, 2008: Beckman to Declare Q1 2008 Results
  - 21.2.6 Feb 08, 2008: Beckman Declares Quarterly Dividend
  - 21.2.7 Feb 08, 2008: Beckman Declares Q4 2007 Results
  - 21.2.8 Jan 23, 2008: Beckman to Declare Q4 2007 Results
  - 21.2.9 Oct 30, 2007: Beckman Declares Q3 2007 Results
  - 21.2.10 Oct 22, 2007: Beckman Declares Quarterly Dividend
  - 21.2.11 Aug 01, 2007: Beckman Declares Q2 2007 Results
  - 21.2.12 Jul 26, 2007: Beckman Declares Quarterly Dividend
  - 21.2.13 May 03, 2007: Beckman Declares Quarterly Dividend
  - 21.2.14 May 02, 2007: Beckman Q1 Revenue Up 7.8% to $613.6 Million
  - 21.2.15 Mar 26, 2007: Beckman Coulter Declares Q4 Results
  - 21.2.16 Nov 01, 2006: Beckman Coulter Announces Q3 2006 Results
  - 21.2.17 Aug 02, 2006: Beckman Coulter Announces Q2 2006 Results
- 21.3 Other Significant Developments
  - 21.3.1 Aug 22, 2008: Beckman Coulters Senior Vice President to Present at the Morgan Stanley Healthcare Unplugged Conference
  - 21.3.2 Feb 08, 2008: Beckman Names New Chairman
  - 21.3.3 Dec 12, 2007: Beckman Elects New Board Member
  - 21.3.4 Jun 04, 2007: Beckman Board Member Resigns
  - 21.3.5 Oct 10, 2006: Beckman Coulter Appoints New Vice President and CFO
  - 21.3.6 Aug 01, 2006: Beckman Announces Arbitration Results With Digene
  - 21.3.7 Apr 27, 2006: Beckman Coulter Provides Information on Applera Settlement
22 Beckman Coulter, Inc. Pipeline Products
- 22.1 Sex Hormone Binding Globulin Test
  - 22.1.1 Product Overview
  - 22.1.2 Product Description
  - 22.1.3 Product Status
- 22.2 sVEGF-R1 assay
  - 22.2.1 Product Overview
  - 22.2.2 Product Description
  - 22.2.3 Product Status
- 22.3 ProClot (Protein C)assay for ACL TOP
  - 22.3.1 Product Overview
  - 22.3.2 Product Description
  - 22.3.3 Product Status
- 22.4 ProS (Protein S) for ACL TOP
  - 22.4.1 Product Overview
  - 22.4.2 Product Description
  - 22.4.3 Product Status
- 22.5 SYNCHRON LXi 725 system(Tricyclics assay)
  - 22.5.1 Product Overview
  - 22.5.2 Product Description
  - 22.5.3 Product Status
- 22.6 Ischemia Modified Albumin
  - 22.6.1 Product Overview
  - 22.6.2 Product Description
  - 22.6.3 Product Status
- 22.7 Access ANA Screen test
  - 22.7.1 Product Overview
  - 22.7.2 Product Description
  - 22.7.3 Product Status
- 22.8 Soluble Transferrin Receptor Test
  - 22.8.1 Product Overview
  - 22.8.2 Product Description
  - 22.8.3 Product Status
- 22.9 PT-Fib for ACL TOP analyzer
  - 22.9.1 Product Overview
  - 22.9.2 Product Description
  - 22.9.3 Product Status
- 22.10 PT-Fib HS for ACL TOP analyzer
  - 22.10.1 Product Overview
  - 22.10.2 Product Description
  - 22.10.3 Product Status
- 22.11 PT-Fib HS Plus for ACL TOP analyzer
  - 22.11.1 Product Overview
  - 22.11.2 Product Description
  - 22.11.3 Product Status
- 22.12 Access Rubella IgM immunocapture assay
  - 22.12.1 Product Overview
  - 22.12.2 Product Description
  - 22.12.3 Product Status
- 22.13 SYNCHRON LXi 725 (Anti-Cardiolipin test)
  - 22.13.1 Product Overview
  - 22.13.2 Product Description
  - 22.13.3 Product Status
- 22.14 Access(ds DNA Ab immunoassay)
  - 22.14.1 Product Overview
  - 22.14.2 Product Description
  - 22.14.3 Product Status
- 22.15 SYNCHRON LXi 725(Anti-dsDNA test)
  - 22.15.1 Product Overview
  - 22.15.2 Product Description
  - 22.15.3 Product Status
- 22.16 Chlamydia test
  - 22.16.1 Product Overview
  - 22.16.2 Product Description
  - 22.16.3 Product Institution Details
  - 22.16.4 Product Status
- 22.17 Neisseria test
  - 22.17.1 Product Overview
  - 22.17.2 Product Description
  - 22.17.3 Product Institution Details
  - 22.17.4 Product Status
  - 22.17.5 Product Milestone
23 Appendix
- 23.1 Global Markets Direct Research Methodology
- 23.2 Coverage
- 23.3 Secondary Research
- 23.4 Primary Research
- 23.5 Models
- 23.6 Forecasts
- 23.7 Expert Panels
- 23.8 Market Revenue Chapters
  - 23.8.1 Abbreviations
  - 23.8.2 Currency Conversions
- 23.9 About Global Markets Direct
- 23.10 Contact Us
- 23.11 Disclaimer
1 List of Tables
- Table 1: Beckman Coulter, Inc., Key Facts, 2007
- Table 2: Beckman Coulter, Inc., SWOT Analysis, 2007
- Table 3: Beckman Coulter, Inc. In Vitro Diagnostics by Geography, Global, Revenue ($ mn) and Market Share (%), 2007
- Table 4: Beckman Coulter, Inc. In Vitro Diagnostics by Geography, APAC, Revenue ($ mn) and Market Share (%), 2007
- Table 5: Beckman Coulter, Inc. In Vitro Diagnostics by Geography, Europe, Revenue ($ mn) and Market Share (%), 2007
- Table 6: Beckman Coulter, Inc. In Vitro Diagnostics by Geography, MEA, Revenue ($ mn) and Market Share (%), 2007
- Table 7: Beckman Coulter, Inc. In Vitro Diagnostics by Geography, North America, Revenue ($ mn) and Market Share (%), 2007
- Table 8: Beckman Coulter, Inc. In Vitro Diagnostics by Geography, SCA, Revenue ($ mn) and Market Share (%), 2007
- Table 9: Beckman Coulter, Inc. Medical Equipment by Category, Global, Revenue ($ mn) and Market Share (%), 2007
- Table 10: Beckman Coulter, Inc. Medical Equipment by Category, APAC, Revenue ($ mn) and Market Share (%), 2007
- Table 11: Beckman Coulter, Inc. Medical Equipment by Category, Australia, Revenue ($ mn) and Market Share (%), 2007
- Table 12: Beckman Coulter, Inc. Medical Equipment by Category, China, Revenue ($ mn) and Market Share (%), 2007
- Table 13: Beckman Coulter, Inc. Medical Equipment by Category, India, Revenue ($ mn) and Market Share (%), 2007
- Table 14: Beckman Coulter, Inc. Medical Equipment by Category, Japan, Revenue ($ mn) and Market Share (%), 2007
- Table 15: Beckman Coulter, Inc. Medical Equipment by Category, Others, Revenue ($ mn) and Market Share (%), 2007
- Table 16: Beckman Coulter, Inc. Medical Equipment by Category, Europe, Revenue ($ mn) and Market Share (%), 2007
- Table 17: Beckman Coulter, Inc. Medical Equipment by Category, France, Revenue ($ mn) and Market Share (%), 2007
- Table 18: Beckman Coulter, Inc. Medical Equipment by Category, Germany, Revenue ($ mn) and Market Share (%), 2007
- Table 19: Beckman Coulter, Inc. Medical Equipment by Category, Italy, Revenue ($ mn) and Market Share (%), 2007
- Table 20: Beckman Coulter, Inc. Medical Equipment by Category, Spain, Revenue ($ mn) and Market Share (%), 2007
- Table 21: Beckman Coulter, Inc. Medical Equipment by Category, United Kingdom, Revenue ($ mn) and Market Share (%), 2007
- Table 22: Beckman Coulter, Inc. Medical Equipment by Category, Others, Revenue ($ mn) and Market Share (%), 2007
- Table 23: Beckman Coulter, Inc. Medical Equipment by Category, MEA, Revenue ($ mn) and Market Share (%), 2007
- Table 24: Beckman Coulter, Inc. Medical Equipment by Category, North America, Revenue ($ mn) and Market Share (%), 2007
- Table 25: Beckman Coulter, Inc. Medical Equipment by Category, Canada, Revenue ($ mn) and Market Share (%), 2007
- Table 26: Beckman Coulter, Inc. Medical Equipment by Category, United States, Revenue ($ mn) and Market Share (%), 2007
- Table 27: Beckman Coulter, Inc. Medical Equipment by Category, SCA, Revenue ($ mn) and Market Share (%), 2007
- Table 28: Beckman Coulter, Inc. Medical Equipment by Category, Brazil, Revenue ($ mn) and Market Share (%), 2007
- Table 29: Beckman Coulter, Inc. Medical Equipment by Category, Others, Revenue ($ mn) and Market Share (%), 2007
- Table 30: Beckman Coulter, Inc., Revenue by Segment, USD Million, 2003-2007
- Table 31: Beckman Coulter, Inc., Revenue by Geography, USD Million, 2003-2007
- Table 32: Beckman Coulter, Inc., Financial Statements, USD Million, 2003-2007
- Table 33: Beckman Coulter, Inc., Financial Ratios, USD Million, 2003-2007
- Table 34: Beckman Coulter, Inc., Share Holding Structure
- Table 35: Beckman Coulter, Inc., Key Employees, 2007
- Table 36: Beckman Coulter, Inc., Other Locations
- Table 37: Beckman Coulter, Inc., Subsidiaries
- Table 38: Abbreviations used in the Market Revenue Chapters
- Table 39: Currency Conversion from USD to Local Currency at 2007 Constant Rate
- 1.2 List of Figures
- Figure 1: Beckman Coulter, Inc., Value Chain Analysis
- Figure 2: Beckman Coulter, Inc. In Vitro Diagnostics, Global, Share of Market (%), 2007
- Figure 3: Beckman Coulter, Inc. In Vitro Diagnostics, APAC, Share of Market (%), 2007
- Figure 4: Beckman Coulter, Inc. In Vitro Diagnostics, Europe, Share of Market (%), 2007
- Figure 5: Beckman Coulter, Inc. In Vitro Diagnostics, North America, Share of Market (%), 2007
- Figure 6: Beckman Coulter, Inc. In Vitro Diagnostics, SCA, Share of Market (%), 2007
- Figure 7: Beckman Coulter, Inc. Medical Equipment by Category, Global, Revenue Share (%), 2007
- Figure 8: Beckman Coulter, Inc. Medical Equipment by Category, Global, Share of Market (%), 2007
- Figure 9: Beckman Coulter, Inc. Medical Equipment by Category, APAC, Revenue Share (%), 2007
- Figure 10: Beckman Coulter, Inc. Medical Equipment by Category, APAC, Share of Market (%), 2007
- Figure 11: Beckman Coulter, Inc. Medical Equipment by Category, Australia, Revenue Share (%), 2007
- Figure 12: Beckman Coulter, Inc. Medical Equipment by Category, Australia, Share of Market (%), 2007
- Figure 13: Beckman Coulter, Inc. Medical Equipment by Category, China, Revenue Share (%), 2007
- Figure 14: Beckman Coulter, Inc. Medical Equipment by Category, China, Share of Market (%), 2007
- Figure 15: Beckman Coulter, Inc. Medical Equipment by Category, India, Revenue Share (%), 2007
- Figure 16: Beckman Coulter, Inc. Medical Equipment by Category, India, Share of Market (%), 2007
- Figure 17: Beckman Coulter, Inc. Medical Equipment by Category, Japan, Revenue Share (%), 2007
- Figure 18: Beckman Coulter, Inc. Medical Equipment by Category, Japan, Share of Market (%), 2007
- Figure 19: Beckman Coulter, Inc. Medical Equipment by Category, Others, Revenue Share (%), 2007
- Figure 20: Beckman Coulter, Inc. Medical Equipment by Category, Others, Share of Market (%), 2007
- Figure 21: Beckman Coulter, Inc. Medical Equipment by Category, Europe, Revenue Share (%), 2007
- Figure 22: Beckman Coulter, Inc. Medical Equipment by Category, Europe, Share of Market (%), 2007
- Figure 23: Beckman Coulter, Inc. Medical Equipment by Category, France, Revenue Share (%), 2007
- Figure 24: Beckman Coulter, Inc. Medical Equipment by Category, France, Share of Market (%), 2007
- Figure 25: Beckman Coulter, Inc. Medical Equipment by Category, Germany, Revenue Share (%), 2007
- Figure 26: Beckman Coulter, Inc. Medical Equipment by Category, Germany, Share of Market (%), 2007
- Figure 27: Beckman Coulter, Inc. Medical Equipment by Category, Italy, Revenue Share (%), 2007
- Figure 28: Beckman Coulter, Inc. Medical Equipment by Category, Italy, Share of Market (%), 2007
- Figure 29: Beckman Coulter, Inc. Medical Equipment by Category, Spain, Revenue Share (%), 2007
- Figure 30: Beckman Coulter, Inc. Medical Equipment by Category, Spain, Share of Market (%), 2007
- Figure 31: Beckman Coulter, Inc. Medical Equipment by Category, United Kingdom, Revenue Share (%), 2007
- Figure 32: Beckman Coulter, Inc. Medical Equipment by Category, United Kingdom, Share of Market (%), 2007
- Figure 33: Beckman Coulter, Inc. Medical Equipment by Category, Others, Revenue Share (%), 2007
- Figure 34: Beckman Coulter, Inc. Medical Equipment by Category, Others, Share of Market (%), 2007
- Figure 35: Beckman Coulter, Inc. Medical Equipment by Category, MEA, Revenue Share (%), 2007
- Figure 36: Beckman Coulter, Inc. Medical Equipment by Category, MEA, Share of Market (%), 2007
- Figure 37: Beckman Coulter, Inc. Medical Equipment by Category, North America, Revenue Share (%), 2007
- Figure 38: Beckman Coulter, Inc. Medical Equipment by Category, North America, Share of Market (%), 2007
- Figure 39: Beckman Coulter, Inc. Medical Equipment by Category, Canada, Revenue Share (%), 2007
- Figure 40: Beckman Coulter, Inc. Medical Equipment by Category, Canada, Share of Market (%), 2007
- Figure 41: Beckman Coulter, Inc. Medical Equipment by Category, United States, Revenue Share (%), 2007
- Figure 42: Beckman Coulter, Inc. Medical Equipment by Category, United States, Share of Market (%), 2007
- Figure 43: Beckman Coulter, Inc. Medical Equipment by Category, SCA, Revenue Share (%), 2007
- Figure 44: Beckman Coulter, Inc. Medical Equipment by Category, SCA, Share of Market (%), 2007
- Figure 45: Beckman Coulter, Inc. Medical Equipment by Category, Brazil, Revenue Share (%), 2007
- Figure 46: Beckman Coulter, Inc. Medical Equipment by Category, Brazil, Share of Market (%), 2007
- Figure 47: Beckman Coulter, Inc. Medical Equipment by Category, Others, Revenue Share (%), 2007
- Figure 48: Beckman Coulter, Inc. Medical Equipment by Category, Others, Share of Market (%), 2007
- Figure 49: Global Markets Direct Methodology